Teleflex (NYSE:TFX) Stock Price Expected to Rise, Mizuho Analyst Says

Key Points

• Mizuho has raised its target price for Teleflex from $130.00 to $135.00, indicating a potential upside of 17.54% from the current price.
• Teleflex reported an EPS of $3.73 for the last quarter, exceeding analysts' expectations, along with a 4.2% increase in revenue year-over-year.
• Current market sentiment shows a mix of ratings: one sell, nine holds, and two buys, with an average price target of $160.13.

Teleflex (NYSE:TFX - Get Free Report) had its target price raised by investment analysts at Mizuho from $130.00 to $135.00 in a report released on Friday,Benzinga reports. The firm currently has a "neutral" rating on the medical technology company's stock. Mizuho's target price suggests a potential upside of 17.54% from the company's current price.

Several other equities research analysts have also issued reports on the stock. Royal Bank Of Canada set a $130.00 target price on shares of Teleflex and gave the stock a "sector perform" rating in a report on Tuesday, July 15th. Wall Street Zen lowered shares of Teleflex from a "buy" rating to a "hold" rating in a report on Sunday, June 29th. Morgan Stanley reduced their target price on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a report on Monday, May 5th. Truist Financial reduced their target price on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a report on Monday, May 5th. Finally, Wells Fargo & Company reduced their target price on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a report on Friday. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, Teleflex has an average rating of "Hold" and an average price target of $160.13.

Teleflex Stock Performance

NYSE:TFX traded down $4.65 during mid-day trading on Friday, reaching $114.86. The company's stock had a trading volume of 178,176 shares, compared to its average volume of 810,753. Teleflex has a 12-month low of $108.90 and a 12-month high of $249.90. The stock has a market cap of $5.08 billion, a P/E ratio of 36.15, a PEG ratio of 1.78 and a beta of 1.08. The company has a current ratio of 2.28, a quick ratio of 1.32 and a debt-to-equity ratio of 0.44. The firm's fifty day moving average price is $118.83 and its two-hundred day moving average price is $137.60.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, beating the consensus estimate of $3.36 by $0.37. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. The firm had revenue of $780.90 million during the quarter, compared to analyst estimates of $771.53 million. During the same quarter in the prior year, the firm earned $3.42 EPS. The business's revenue for the quarter was up 4.2% compared to the same quarter last year. On average, equities analysts forecast that Teleflex will post 13.98 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Headlands Technologies LLC purchased a new position in shares of Teleflex in the fourth quarter valued at $29,000. Banque Cantonale Vaudoise purchased a new position in shares of Teleflex in the first quarter valued at $27,000. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Teleflex by 103.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock valued at $27,000 after purchasing an additional 100 shares in the last quarter. Costello Asset Management INC purchased a new position in shares of Teleflex in the first quarter valued at $28,000. Finally, Brooklyn Investment Group grew its holdings in shares of Teleflex by 258.6% in the first quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company's stock valued at $29,000 after purchasing an additional 150 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.